Beyond Medical Technologies Inc Statistics
Want to see TSE:DOCT full AI Analyst Report?
Beyond Medical Technologies Inc (DOCT) Stock Statistics & Valuation Metrics
Total Valuation
Beyond Medical Technologies Inc has a market cap or net worth of CAD 5.57M. The enterprise value is CAD 13.67M.
- Market Cap
- CAD 5.57M
- Enterprise Value
- CAD 13.67M
Share Statistics
Beyond Medical Technologies Inc has 32,793,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 32,793,960
- Owned by Insiders
- 9.85%
- Owned by Institutions
- ―
Financial Efficiency
Beyond Medical Technologies Inc’s return on equity (ROE) is -20.09 and return on invested capital (ROIC) is -16.58%.
- Return on Equity (ROE)
- -20.09
- Return on Assets (ROA)
- -0.17
- Return on Invested Capital (ROIC)
- -16.58%
- Return on Capital Employed (ROCE)
- -0.23
- Revenue Per Employee
- 3,828
- Profits Per Employee
- -894.03K
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Beyond Medical Technologies Inc is -0.63. Beyond Medical Technologies Inc’s PEG ratio is 0.00.
- PE Ratio
- -0.63
- PS Ratio
- -1459.54
- PB Ratio
- -1.17
- Price to FCF
- -1.40
- Price to Operating Cash Flow
- -1.40
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Beyond Medical Technologies Inc had revenue of 11.48K and earned -2.68M in profits. Earnings per share was -0.10.
- Revenue
- 11.48K
- Gross Profit
- 11.48K
- Operating Income
- -1.99M
- Pretax Income
- -2.68M
- Net Income
- -2.68M
- EBITDA
- -2.09M
- Earnings Per Share (EPS)
- -0.10
Cash Flow
In the last 12 months, operating cash flow was -3.75M and capital expenditures 8, giving a free cash flow of -3.75M billion.
- Operating Cash Flow
- -3.75M
- Free Cash Flow
- -3.75M
- Free Cash Flow per Share
- -0.11
Dividends & Yields
Beyond Medical Technologies Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -71.48%
- Earnings Yield
- -160.28%
Stock Price Statistics
- Beta
- 1.31
- 52-Week Price Change
- -56.41%
- 50-Day Moving Average
- 0.17
- 200-Day Moving Average
- 0.17
- Relative Strength Index (RSI)
- 47.83
- Average Volume (3m)
- 3,218
Important Dates
Beyond Medical Technologies Inc upcoming earnings date is Nov 26, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 01, 2026
- Next Earnings Date
- Nov 26, 2026
- Ex-Dividend Date
- ―
Financial Position
Beyond Medical Technologies Inc as a current ratio of 0.77, with Debt / Equity ratio of 8880.64%
- Current Ratio
- 0.77
- Quick Ratio
- 0.77
- Debt to Market Cap
- 1.93
- Net Debt to EBITDA
- -4.35
- Interest Coverage Ratio
- -3.36
Taxes
In the past 12 months, Beyond Medical Technologies Inc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Beyond Medical Technologies Inc EV to EBITDA ratio is -23.12, with an EV/FCF ratio of -4.37.
- EV to Sales
- -4563.28
- EV to EBITDA
- -23.12
- EV to Free Cash Flow
- -4.37
- EV to Operating Cash Flow
- -4.37
Balance Sheet
Beyond Medical Technologies Inc has CAD 1.81M in cash and marketable securities with CAD 11.38M in debt, giving a net cash position of -CAD 9.57M billion.
- Cash & Marketable Securities
- CAD 1.81M
- Total Debt
- CAD 11.38M
- Net Cash
- -CAD 9.57M
- Net Cash Per Share
- -CAD 0.29
- Tangible Book Value Per Share
- -CAD 0.29
Margins
Gross margin is 2634.46%, with operating margin of 59166.09%, and net profit margin of 233930.46%.
- Gross Margin
- 2634.46%
- Operating Margin
- 59166.09%
- Pretax Margin
- 240133.52%
- Net Profit Margin
- 233930.46%
- EBITDA Margin
- 19738.61%
- EBIT Margin
- 29328.43%
Analyst Forecast
The average price target for Beyond Medical Technologies Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -156.09%
Scores
- Smart Score
- ―
- AI Score
- 44
